API
< Back to all clusters
[BUSINESS] · Australia, United States · 2 sources

started · updated

ResMed reports strong quarterly earnings and dividend

ResMed, a leading sleep apnea device manufacturer, reported first-quarter revenue of US$1.4 billion, representing a 6% increase from the previous year and exceeding market expectations. Earnings per share rose 14% during the period, defying previous predictions of contraction.

Chief Executive and Chairman Mick Farrell attributed the results to gross margin appreciation and growth within the company’s digital health ecosystem. ResMed has reached milestones of 36 million cloud-connected medical devices sold and over 13 million downloads of its myAir sleep coaching app.

The company also announced a new partnership with Eight Sleep, a smart mattress company, to integrate sleep tracking capabilities. Additionally, ResMed confirmed it will maintain its quarterly dividend at $0.66 per share, with the next payment scheduled for December 17 for shareholders of record as of November 12.

Entities

Eight Sleep · Mick Farrell · RBC Capital Markets · ResMed